Related Experiment Video
Updated: Jul 7, 2026

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
Published on: June 24, 2025
Lytic bacteriophages active in urine against multidrug-resistant clinically derived Klebsiella pneumoniae causing
Ruxandra Calin1, Blanca Bernabeu Vilaplana2, Judeline Gedeon3
1Mucosal Inflammation and Immunity Team, Université Paris Cité, CNRS, Inserm, Institut Cochin, F-75014 Paris, France & Department of Immunology, Institut Pasteur, Paris, France; AP-HP Sorbonne-Université, Hôpital Tenon, Service Maladies Infectieuses et Tropicales, Paris, France.
Objectives:
Multidrug-resistant (MDR) Klebsiella pneumoniae is an increasingly important cause of recurrent urinary tract infections (UTIs). As bacteriophage therapy represents a promising alternative, we aimed to isolate and characterize bacteriophages targeting a clinical MDR K. pneumoniae strain causing recurrent UTI and evaluate their activity under urinary conditions.
Methods:
Three bacteriophages targeting an extended-spectrum beta-lactamase-producing K. pneumoniae clinical isolate were obtained and characterized by genome sequencing, electron microscopy, stability assays, one-step growth curves, and host-range analysis across 79 UTI isolates. Phage activity was quantified in Luria-Bertani medium and human urine.
Results:
Three lytic phages (EDIRA083, EDIRA088, and EDIRA092) belonging to distinct genera were identified. Absence of lysogeny-associated, virulence, or antibiotic-resistance genes was confirmed. Capsule, lipopolysaccharide, and maltoporin LamB were identified as receptors for EDIRA083 and EDIRA092. Host-range analysis revealed narrow activity for EDIRA083 and EDIRA088, whereas EDIRA092 infected 29% of the panel strains. In liquid phage infection assays, overall lytic activity was consistently higher and more sustained in human urine than in Luria-Bertani.
Conclusions:
These results identify three genetically distinct lytic phages targeting MDR K. pneumoniae. Their activity in urine supports further evaluation of these phages as candidates for therapeutic development against MDR Klebsiella UTI.
Insights
Three novel bacteriophages were identified that effectively target multidrug-resistant Klebsiella pneumoniae causing urinary tract infections (UTIs). These phages demonstrated enhanced lytic activity in human urine, supporting their potential for therapeutic development against resistant infections.
Area of Science:
- Microbiology
- Virology
- Infectious Diseases
Background:
- Multidrug-resistant (MDR) Klebsiella pneumoniae is a growing threat, particularly in recurrent urinary tract infections (UTIs).
- Bacteriophage therapy offers a potential alternative to antibiotics for treating MDR bacterial infections.
Purpose of the Study:
- To isolate and characterize bacteriophages effective against a clinical MDR K. pneumoniae strain responsible for recurrent UTIs.
- To evaluate the activity of these bacteriophages under conditions mimicking the human urinary tract.
Main Methods:
- Isolation and characterization of three lytic bacteriophages targeting an ESBL-producing K. pneumoniae.
- Genome sequencing, electron microscopy, stability assays, growth curves, and host-range analysis.
- Quantification of phage activity in both LB medium and human urine.
Main Results:
- Three distinct lytic phages (EDIRA083, EDIRA088, EDIRA092) were identified, lacking lysogeny, virulence, or antibiotic-resistance genes.
- Capsule, LPS, and LamB were identified as receptors for two phages; one phage infected 29% of tested strains.
- Phage lytic activity was significantly higher and more sustained in human urine compared to LB medium.
Conclusions:
- Three genetically distinct lytic phages targeting MDR K. pneumoniae were successfully identified.
- The demonstrated activity of these phages in urine supports their potential as therapeutic candidates for Klebsiella UTIs.
- Further evaluation is warranted for the development of phage-based therapies against MDR K. pneumoniae infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
Urinary Tract Infection I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection II: Pathophysiology
Bacteriophages of the Human Virome
Urine Studies II: Urine Culture and Sensitivity Test
